Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Open accessThe DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index; none of the 132 sources its claims cite is checked for support yet.
Abstract
The global prevalence of early-onset type 2 diabetes (EOT2D) is rising rapidly. Adults with EOT2D represent a high-risk population characterised by increased rates of microvascular and macrovascular complications, adverse psychological wellbeing and psychiatric comorbidities such as depression, and premature mortality compared to those with later-onset type 2 diabetes mellitus. This emerging population faces unique challenges, including high levels of diabetes-related stigma, clinical inertia, and competing life demands, such as starting a family. This review synthesises current evidence on the clinical management of EOT2D. Key therapeutic targets include weight reduction, preservation of β-cell function, cardiometabolic risk management, and psychological support. Overall, there are few randomized controlled trials (RCTs) undertaken specifically in adults with EOT2D. However, we summarise early data from the few RCTs that do report outcomes specific in young adults, with bariatric surgery, tirzepatide and intensive lifestyle interventions emerging as particularly effective treatments. There is a strong rationale that technology-based inventions and structured education programs may prove to be effective treatments but data from RCTs is lacking. We provide broad recommendations for future research and clinical practice based on the current evidence. In conclusion, substantial further research is required to inform tailored, evidence-based guidelines and improve long-term outcomes in this underserved population.
Overview
CoChat Summary
TL;DR
This narrative review summarizes current evidence on managing early-onset type 2 diabetes (EOT2D; diagnosis <40 years) in adults, a high-risk group with more complications, mental-health burden, and premature mortality than later-onset T2DM. It finds the strongest RCT/subanalysis signals for tirzepatide, bariatric surgery, and intensive lifestyle intervention, but concludes dedicated trials and tailored guidelines are urgently needed.
Key findings
- EOT2D accounts for 15% to 20% of adults diagnosed with T2DM worldwide and is associated with higher microvascular and macrovascular disease, mortality, and psychological burden; 50% of adults with EOT2D report moderate-to-high diabetes distress versus 19% among those diagnosed with T2DM aged ≥60 years.
- In the VERIFY subanalysis, adults with EOT2D (n=186; 9.3%) versus later-onset T2DM (n=1,815; 90.7%) had 5-year treatment failure (HbA1c ≥7.0%) of 50.5% with metformin plus vildagliptin versus 73.3% with metformin monotherapy in EOT2D; later-onset rates were 42.9% versus 61.0%. In the SURPASS post hoc analysis, SURPASS-2 included ~22.0% EOT2D (n=1,878); at 40 weeks, tirzepatide 15 mg reduced HbA1c by –2.6% versus –1.9% with semaglutide 1 mg, with 93.5% versus 75.3% achieving HbA1c <7.0%, and greater weight reduction (–14.0% vs. –5.4%).
- Bariatric surgery observational data showed higher T2DM remission in EOT2D than later-onset T2DM at 1 year (56.9% vs. 50.2%) and 5 years (65.3% vs. 54.2%), plus greater 5-year weight loss (30.4% vs. 21.6%). The DIADEM-I intensive lifestyle RCT reported 12-month weight loss of –12.0 kg versus –4.0 kg with standard care and diabetes remission of 61.4% versus 11.6%; DiRECT remission fell from 46% at 1 year to 12.9% at 5 years (7% by intention-to-treat).
- A CGM umbrella review found an HbA1c mean difference of –0.40% (95% CI, –0.54 to –0.25) in T2DM; one internet-based DSMES RCT in Chinese young adults (n=60 per group) showed greater 12-month HbA1c reduction (–1.8% vs. –1.2%, P<0.001) and remission (60% vs. 37%, P=0.03), but no RCTs specifically evaluated CGM, insulin pumps, or closed-loop therapy in adults with EOT2D.
Methods
- Design: narrative review synthesizing current evidence on clinical management of EOT2D in adults; children and pregnancy management were excluded from scope.
- Data/sample: cites RCTs, RCT subanalyses/post hoc analyses, observational studies, and systematic/umbrella reviews; no primary data collection. Dedicated EOT2D RCT evidence is limited to a few trials/subanalyses, including VERIFY, SURPASS, DIADEM-I, a small CGM-guided pilot, and an internet-based DSMES trial.
- Main analysis: narrative synthesis and broad recommendations for practice and future research; no systematic search strategy, meta-analysis, or formal risk-of-bias assessment is described.
Limitations
- Stated: few RCTs have been undertaken specifically in adults with EOT2D; young adults aged 18 to 39 years represent <5% of participants in prominent clinical trials; no specific clinical guidelines exist; long-term and hard clinical outcome data are lacking; the internet-based DSMES trial’s generalisability is limited to Chinese young adults, and sustainability questions remain.
- Evident: as a narrative review, it does not report a systematic search, inclusion criteria, or quality appraisal, so selection and synthesis may be non-exhaustive.
- Evident: many conclusions rely on subanalyses, post hoc analyses, or observational data rather than dedicated RCTs in EOT2D, and the authors avoid specific combination-therapy recommendations because direct comparisons are limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
0 Valid · 6 Not valid · 74 Not checked · 33 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is therefore unsurprising that there are no specific clinical guidelines for the management of EOT2D.”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTRODUCTION
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“To date, only one RCT has assessed the impact of an intensive lifestyle intervention on diabetes-related outcomes in adults with EOT2D.”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Lifestyle interventions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Currently, only two RCTs have reported data surrounding the effectiveness of pharmacological treatment in adults with EOT2D in sub-analyses of larger RCTs [65,66].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Pharmacological interventions
What the sources say
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, there remains a dearth of studies investigating the impact of lifestyle interventions in adults with EOT2D [22].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Lifestyle interventions
What the sources say
- Not checked yetcites [22] matched to “Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials” (2020) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Moreover, people with EOT2D remain underrepresented in research focused on DSMES [22].”
§ Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions > INTERVENTIONS TO IMPROVE OUTCOMES IN ADULTS WITH EOT2D > Diabetes self-management education and support
What the sources say
- Not checked yetcites [22] matched to “Adults with early-onset type 2 diabetes (aged 18–39 years) are severely underrepresented in diabetes clinical research trials” (2020) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 113 claims and to verify the 124 references still open.
- It may state two separate claims as one. 33
- Probably not a substantial claim. 14
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent recommendations for the management of EOT2D have highlighted the importance of mental well‐being, identifying it as an essential component of care and a key treatment target.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“In addition to physical complications, existing evidence suggests that EOT2D is associated with unique psychosocial challenges and an increased risk of mental health comorbidities (the presence of two or more conditions), such as anxiety, depression and diabetes‐related distress.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“Young adults may now represent 15%–20% of all adults diagnosed with T2D globally.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“This is of great importance given the increased risk of EOT2D among individuals of non‐White ethnicity.”
From Psychosocial care and experiences in young adults living with early‐onset type 2 diabetes: A narrative review (2026) · cites this paper as [4]
In the citing paper
“In a population facing long disease duration and elevated lifetime risk of cardio-renal events, such continuous, context-rich monitoring offers a plausible pathway to better cardiometabolic risk factor control and clinical outcomes, although head-to-head comparisons of CGM efficacy and hard endpoints (hospitalization, cardiovascular and kidney events, mortality) between people with EOT2D and usual”
From Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook (2026) · cites this paper as [28]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Claggett, B., de Boer, R. A., DeMets, D., Hernandez, A. F., Inzucchi, S. E., Kosiborod, M. N., Lam, C. S. P., Martinez, F., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206286 · Cited by 2,884
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104 · cited 3×
“Indeed, intensive interventions incorporating very-low energy diets and increased physical activity have been increasingly recognised as effective methods of improving T2DM management in adults and children [74].”
InfluentialSelf-citationU.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
(2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.334 · Cited by 1,162 · cited 1×
“Notably, magnitudes of weight loss exceeding 10% can lead to remission of T2DM [26-29].”
Mechanism linking diabetes mellitus and obesity
Algoblan, A., Alalfi, M., & Khan, M. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s67400 · Cited by 1,028
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Chrvala, C. A., Sherr, D., & Lipman, R. D. (2016) · Patient Education and Counseling · doi:10.1016/j.pec.2015.11.003 · Cited by 914
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 878
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Weng, J., Li, Y., Xu, W., Shi, L., Zhang, Q., Zhu, D., Hu, Y., Zhou, Z., Yan, X., Tian, H., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60762-x · Cited by 780
Davies, M. J., Heller, S., Skinner, T. C., Campbell, M. J., Carey, M. E., Cradock, S., Dallosso, H. M., Daly, H., Doherty, Y., Eaton, S., et al. (2008) · BMJ · doi:10.1136/bmj.39474.922025.be · Cited by 760
Self-citationGlobal Prevalence of Hypertension in Children: A Systematic Review and Meta-analysis
Song, P., Zhang, Y., Yu, J., Zha, M., Zhu, Y., Rahimi, K., & Rudan, I. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2019.3310 · Cited by 732
Holt, R. I. G., DeVries, J. H., Hess-Fischl, A., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., et al. (2021) · Diabetes Care · doi:10.2337/dci21-0043 · Cited by 699
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635
Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
Lingvay, I., Sumithran, P., Cohen, R. V., & le Roux, C. W. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01919-x · Cited by 581 · cited 1×
“The benefits of weight loss also far exceed those related specifically to glucose control, with de-monstrable improvements observed in cardiometabolic risk factors and quality of life [30].”
Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Long-term complications in youth-onset type 2 diabetes
TODAY Study Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100165 · Cited by 546
Martens, T., Beck, R. W., Bailey, R., Ruedy, K. J., Calhoun, P., Peters, A. L., Pop-Busui, R., Philis-Tsimikas, A., Bao, S., Umpierrez, G., et al. (2021) · JAMA · doi:10.1001/jama.2021.7444 · Cited by 543
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s010 · Cited by 495
Roizen, M. F. (2011) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2011.01.029 · Cited by 487
Type 2 diabetes mellitus and psychological stress — a modifiable risk factor
Hackett, R. A., & Steptoe, A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.64 · Cited by 480 · cited 1×
“These psychological difficulties are strongly associated with poorer quality of life, suboptimal glycemic control, and a heightened risk of diabetes-related complications [55].”
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411 · cited 1×
“Digital-based DSMES can support people to ‘live well’ with diabetes [107], showing promising and often comparable outcomes to face-to-face programmes [108,109].”
Taheri, S., Zaghloul, H., Chagoury, O., Elhadad, S., Ahmed, S. H., El Khatib, N., Amona, R. A., El Nahas, K., Suleiman, N., Alnaama, A., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30117-0 · Cited by 393
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Drucker, D. J. (2024) · Diabetes Care · doi:10.2337/dci24-0003 · Cited by 383
Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults
Inge, T. H., Courcoulas, A. P., Jenkins, T. M., Michalsky, M. P., Brandt, M. L., Xanthakos, S. A., Dixon, J. B., Harmon, C. M., Chen, M. K., Xie, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813909 · Cited by 381 · cited 2×
“Individuals with EOT2D tend to exhibit higher rates of diabetes remission and more substantial weight reduction following bariatric surgery, suggesting a heightened therapeutic benefit in this subgroup [26,70].”
Diabetes structured self-management education programmes: a narrative review and current innovations
Chatterjee, S., Davies, M. J., Heller, S., Speight, J., Snoek, F. J., & Khunti, K. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30239-5 · Cited by 372
Self-citationMatthews, D. R., Paldánius, P. M., Proot, P., Chiang, Y., Stumvoll, M., & Del Prato, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32131-2 · Cited by 364 · cited 2×
“Failure rates in both treatment groups were higher in the EOT2D population compared to the later-onset T2DM population (42.9% with early combination therapy; 61.0% with monotherapy) [65,67].”
InfluentialLiraglutide in Children and Adolescents with Type 2 Diabetes
Tamborlane, W. V., Barrientos-Pérez, M., Fainberg, U., Frimer-Larsen, H., Hafez, M., Hale, P. M., Jalaludin, M. Y., Kovarenko, M., Libman, I., Lynch, J. L., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903822 · Cited by 357
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349 · cited 2×
“It is important to note that children are outside the scope of this review, due to physiological differences and differences in licenced medication between adults and children, and because there are already specific guidelines available for the management of T2DM in children [23,24].”
What is the pipeline for future medications for obesity?
Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01473-y · Cited by 332 · cited 2×
“National formulary inclusion, prescribing restrictions, healthcare system infrastructure, and socioeconomic disparities may limit affordability and availability, particularly in un-derserved populations [118].”
Self-citationInvesting in the Health and Well-Being of Young Adults
Institute of Medicine and National Research Council (2015) · National Academies Press eBooks · doi:10.17226/18869 · Cited by 320
Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2012) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 301
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70137-8 · Cited by 296
TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288 · cited 2×
“…with T2DM experienced a 20% to 35% annual decline in β-cell function, which is significantly higher than the ~7% decline seen in older individuals [43-45]. β-Cell dysfunction is associated with impaired glycemic control and a greater likelihood of treatment failure in both younger and older…”
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
The burden of diabetes-associated multiple long-term conditions on years of life spent and lost
Gregg, E. W., Pratt, A. C., Owens, A., Barron, E., Dunbar-Rees, R., Slade, E. T., Hafezparast, N., Bakhai, C., Chappell, P., Cornelius, V. R., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03123-2 · Cited by 283
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s009 · Cited by 271
Yoo, H. J., An, H. G., Park, S. Y., Ryu, O. H., Kim, H. Y., Seo, J. A., Hong, E. G., Shin, D. H., Kim, Y. H., Kim, S. G., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.015 · Cited by 244
Reznik, Y., Cohen, O., Aronson, R., Conget, I., Runzis, S., Castaneda, J., & Lee, S. W. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61037-0 · Cited by 233
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s013 · Cited by 223 · cited 1×
“Lifestyle modifications (i.e., changes to 24-hour physical behaviors, such as physical activity, sedentary time, sleep, structured exercise, and diet) are also fundamental components of T2DM management [71-73].”
Current insights and emerging trends in early-onset type 2 diabetes
Misra, S., Ke, C., Srinivasan, S., Goyal, A., Nyriyenda, M. J., Florez, J. C., Khunti, K., Magliano, D. J., & Luk, A. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00225-5 · Cited by 222
Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents
Inge, T. H., Laffel, L. M., Jenkins, T. M., Marcus, M. D., Leibel, N. I., Brandt, M. L., Haymond, M., Urbina, E. M., Dolan, L. M., Zeitler, P. S., et al. (2018) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.5763 · Cited by 189
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186 · cited 1×
“For example, in the Diabetes Remission Clinical Trial (DiRECT), which employed a similar low-energy diet approach, diabetes remission was observed in 46% of participants at 1 year, but dropped to only 12.9% after 5 years (7% following intention-to-treat-analysis) [28].”
InfluentialAllen, N. A., Fain, J. A., Braun, B., & Chipkin, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.01.006 · Cited by 182
Intermittently scanned continuous glucose monitoring for type 1 diabetes
Leelarathna, L., Evans, M. L., Neupane, S., Rayman, G., Lumley, S., Cranston, I., Narendran, P., Barnard-Kelly, K., Sutton, C. J., Elliott, R. A., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2205650 · Cited by 174 · cited 1×
“Device technologies, including CGM sensors, insulin pumps, and closed-loop insulin therapy, have been recommended internationally for individuals with type 1 diabetes mellitus based on robust evidence supporting their effectiveness in improving glycemic control and quality of life [79-83].”
Self-citationPremature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis
Chan, J. C. N., Lau, E. S. H., Luk, A. O. Y., Cheung, K. K. T., Kong, A. P. S., Yu, L. W. L., Choi, K.-C., Chow, F. C. C., Ozaki, R., Brown, N., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.03.018 · Cited by 164
The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0244 · Cited by 162
Prevalence and associations of psychological distress in young adults with Type 1 diabetes
Hislop, A. L., Fegan, P. G., Schlaeppi, M. J., Duck, M., & Yeap, B. B. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02310.x · Cited by 158 · cited 1×
“This is driven by a multitude of factors including complex and busy lifestyles (e.g., starting a family, education, and employment responsibilities) that may make accessing care in current health-systems difficult [15,112,113].”
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
Arslanian, S. A., Hannon, T., Zeitler, P., Chao, L. C., Boucher-Berry, C., Barrientos-Pérez, M., Bismuth, E., Dib, S., Cho, J. I., & Cox, D. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2204601 · Cited by 150
Predictors of medication adherence in patients with type 2 diabetes mellitus
Curkendall, S. M., Thomas, N., Bell, K. F., Juneau, P. L., & Weiss, A. J. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.821056 · Cited by 148
Pal, K., Dack, C., Ross, J., Michie, S., May, C., Stevenson, F., Farmer, A., Yardley, L., Barnard, M., & Murray, E. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8439 · Cited by 139
A Systematic Review of Commercial Hybrid Closed-Loop Automated Insulin Delivery Systems
Peacock, S., Frizelle, I., & Hussain, S. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01394-5 · Cited by 122
The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0243 · Cited by 115
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00915.x · Cited by 106 · cited 1×
“EOT2D is associated with a rapid decline in β-cell function [39-42].”
Laffel, L. M., Danne, T., Klingensmith, G. J., Tamborlane, W. V., Willi, S., Zeitler, P., Neubacher, D., Marquard, J., Bardymova, T., Barrientos Perez, M., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00387-4 · Cited by 106
Winkley, K., Evwierhoma, C., Amiel, S. A., Lempp, H. K., Ismail, K., & Forbes, A. (2015) · Diabetic Medicine · doi:10.1111/dme.12556 · Cited by 91
Browne, J. L., Nefs, G., Pouwer, F., & Speight, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12566 · Cited by 89
Ke, C., Lau, E., Shah, B. R., Stukel, T. A., Ma, R. C., So, W.-Y., Kong, A. P., Chow, E., Clarke, P., Goggins, W., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-1900 · Cited by 85
Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review
Almigbal, T. H., Alzarah, S. A., Aljanoubi, F. A., Alhafez, N. A., Aldawsari, M. R., Alghadeer, Z. Y., & Alrasheed, A. A. (2023) · Medicina · doi:10.3390/medicina59010182 · Cited by 79
Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes
Katz, L. L., Anderson, B. J., McKay, S. V., Izquierdo, R., Casey, T. L., Higgins, L. A., Wauters, A., Hirst, K., Nadeau, K. J., & for the TODAY Study Group (2016) · Diabetes Care · doi:10.2337/dc15-2296 · Cited by 72
Lin, B., Coleman, R. L., Bragg, F., Maddaloni, E., Holman, R. R., & Adler, A. I. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00242-0 · Cited by 72
Lind, N., Christensen, M. B., Hansen, D. L., & Nørgaard, K. (2024) · Diabetes Care · doi:10.2337/dc23-2194 · Cited by 71
Digital coaching strategies to facilitate behavioral change in type 2 diabetes: a systematic review
Gershkowitz, B. D., Hillert, C. J., & Crotty, B. H. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa850 · Cited by 67 · cited 1×
“Digital-based DSMES can support people to ‘live well’ with diabetes [107], showing promising and often comparable outcomes to face-to-face programmes [108,109].”
Hadjiconstantinou, M., Byrne, J., Bodicoat, D. H., Robertson, N., Eborall, H., Khunti, K., & Davies, M. J. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5991 · Cited by 63
Self-citationThe needs, concerns, and characteristics of younger Australian adults with Type 2 diabetes
Browne, J. L., Scibilia, R., & Speight, J. (2013) · Diabetic Medicine · doi:10.1111/dme.12078 · Cited by 63
Dibato, J. E., Montvida, O., Zaccardi, F., Sargeant, J. A., Davies, M. J., Khunti, K., & Paul, S. K. (2020) · Diabetes Care · doi:10.2337/dc20-2045 · Cited by 59
Self-citationKe, C., Stukel, T. A., Shah, B. R., Lau, E., Ma, R. C., So, W.-Y., Kong, A. P., Chow, E., Chan, J. C. N., & Luk, A. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003316 · Cited by 57
Nanayakkara, N., Pease, A. J., Ranasinha, S., Wischer, N., Andrikopoulos, S., de Courten, B., & Zoungas, S. (2018) · Diabetic Medicine · doi:10.1111/dme.13660 · Cited by 48
Melson, E., Miras, A. D., & Papamargaritis, D. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-0144 · Cited by 46
Li, L., Ji, L., Guo, X., Ji, Q., Gu, W., Zhi, X., Li, X., Kuang, H., Su, B., Yan, J., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.08.010 · Cited by 46
Sargeant, J. A., Brady, E. M., Zaccardi, F., Tippins, F., Webb, D. R., Aroda, V. R., Gregg, E. W., Khunti, K., & Davies, M. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05174-9 · Cited by 46
Self-citationMisra, S., Holman, N., Barron, E., Knighton, P., Warner, J., Kar, P., Young, B., & Valabhji, J. (2023) · Diabetic Medicine · doi:10.1111/dme.14940 · Cited by 46
Arslanian, S. A., El ghormli, L., Kim, J. Y., Tjaden, A. H., Barengolts, E., Caprio, S., Hannon, T. S., Mather, K. J., Nadeau, K. J., Utzschneider, K. M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2134 · Cited by 45
Koye, D. N., Ling, J., Dibato, J., Khunti, K., Montvida, O., & Paul, S. K. (2020) · Diabetes Care · doi:10.2337/dc20-0417 · Cited by 41
Chesser, H., Srinivasan, S., Puckett, C., Gitelman, S. E., & Wong, J. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221139873 · Cited by 40 · cited 1×
“…a few small RCTs (sample size ≤24 participants) in paediatric populations and young adults (aged ≤21 years) have demonstrated that consistent CGM use for ≤3 months may be beneficial for improving glycemic control and quality of life, with no increase in disease burden with technology use [95-97].”
Barker, M. M., Davies, M. J., Zaccardi, F., Brady, E. M., Hall, A. P., Henson, J. J., Khunti, K., Lake, A., Redman, E. L., Rowlands, A. V., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1237 · Cited by 40
Self-citationDiabetes-specific family conflict and responsibility among emerging adults with type 1 diabetes.
Campbell, M. S., Wang, J., Cheng, Y. I., Cogen, F. R., Streisand, R. M., & Monaghan, M. C. (2019) · Journal of Family Psychology · doi:10.1037/fam0000537 · Cited by 40
Trief, P. M., Kalichman, S. C., Wang, D., Drews, K. L., Anderson, B. J., Bulger, J. D., & Weinstock, R. S. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109216 · Cited by 39
Huang, J.-X., Liao, Y.-F., & Li, Y.-M. (2019) · Current Medical Science · doi:10.1007/s11596-019-2102-7 · Cited by 39
Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes
Aung, L., Lee, W.-J., Chen, S. C., Ser, K.-H., Wu, C.-C., Chong, K., Lee, Y.-C., & Chen, J.-C. (2016) · JAMA Surgery · doi:10.1001/jamasurg.2016.1130 · Cited by 37
Tan, Y. Y., Suan, E., Koh, G. C. H., Suhairi, S. B., & Tyagi, S. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01459-2 · Cited by 35
Long-Term Complications in Youth-Onset Type 2 Diabetes
Nelson, R. G., Hanson, R. L., & Knowler, W. C. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2114053 · Cited by 34
Identifying barriers and facilitators to self care in young adults with type 2 diabetes
Wong, S. K. W., Soon, W., Griva, K., & Smith, H. E. (2024) · Diabetic Medicine · doi:10.1111/dme.15229 · Cited by 33
Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes
Gopalan, A., Mishra, P., Alexeeff, S. E., Blatchins, M. A., Kim, E., Man, A., Karter, A. J., & Grant, R. W. (2020) · Diabetes Care · doi:10.2337/dc19-1380 · Cited by 33
Gogineni, P., Melson, E., Papamargaritis, D., & Davies, M. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2356254 · Cited by 32
Self-citationConway, R. B., Snell-Bergeon, J., Honda-Kohmo, K., Peddi, A. K., Isa, S. B., Sulong, S., Sibomana, L., Gerard Gonzalez, A., Song, J., Lomax, K. E., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae210 · Cited by 31
Schwennesen, N., Henriksen, J. E., & Willaing, I. (2016) · Scandinavian Journal of Caring Sciences · doi:10.1111/scs.12245 · Cited by 26
Chan, J. C. N., Paldánius, P. M., Mathieu, C., Stumvoll, M., Matthews, D. R., & Del Prato, S. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14192 · Cited by 24
Baek, H.-S., Park, J., Yu, J. S., Lee, J., Yang, Y., Ha, J., Lee, S., Cho, J., Lim, D., & Kim, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1501 · Cited by 24
Weinstock, R. S., Trief, P. M., Burke, B. K., Wen, H., Liu, X., Kalichman, S., Anderson, B. J., & Bulger, J. D. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.36964 · Cited by 23
Quinn, L. M., Davies, M. J., Northern, A., Brough, C., Schreder, S., Stribling, B., Khunti, K., & Hadjiconstantinou, M. (2021) · Diabetic Medicine · doi:10.1111/dme.14469 · Cited by 21
Self-citationLascar, N., Altaf, Q.-A., Raymond, N. T., E. P. Brown, J., Pattison, H., Barnett, A., Bailey, C. J., & Bellary, S. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1638239 · Cited by 19
Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis
Barker, M. M., Zaccardi, F., Brady, E. M., Gulsin, G. S., Hall, A. P., Henson, J., Htike, Z. Z., Khunti, K., McCann, G. P., Redman, E. L., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.260 · Cited by 19
Self-citationXu, L., Ran, J., Shao, H., Chen, M., Tang, H., Li, Y., Xu, Y., Huang, Y., Tao, F., Liu, Z., et al. (2025) · Diabetes Care · doi:10.2337/dc24-1699 · Cited by 19
Challenging diabetes stigma starts and ends with all of us
Speight, J., & Holmes-Truscott, E. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00084-0 · Cited by 18
Long term complications in youth-onset type 2 diabetes
Bjornstad, P., Drews, K., Caprio, S., Gubitosi-Klug, R., Nathan, D., Tesfaldet, B., Tryggestad, J., White, N., & Zeitler, P. (2022) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.19.12.3 · Cited by 15
Zeitler, P., Galindo, R. J., Davies, M. J., Bergman, B. K., Thieu, V. T., Nicolay, C., Allen, S., Heine, R. J., & Lee, C. J. (2024) · Diabetes Care · doi:10.2337/dc23-2356 · Cited by 14
Self-citationMakda, S. I., Davies, M. J., Wilmot, E., Bankart, J., Yates, T., Varghese, E. M., Fisher, H., Anwar, A., & Khunti, K. (2013) · Diabetic Medicine · doi:10.1111/dme.12051 · Cited by 14
Self-citationSGLT2 Inhibitors in Type 2 Diabetes Mellitus
Ferrannini, G., Savarese, G., & Cosentino, F. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.03.009 · Cited by 13
Type 2 diabetes and accelerated ageing in skeletal muscle
Henson, J. J., Baker, L. A., Watson, E. L., Yates, T. E., & Davies, M. J. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00061-0 · Cited by 11
Self-citationDasgupta, K., Boulé, N. G., Henson, J. J., Chevalier, S., Redman, E., Chan, D., McCarthy, M., Champagne, J., Arsenyadis, F., Rees, J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063888 · Cited by 11
Self-citationThe impact of diabetes technology advances on quality of life: addressing the barriers to uptake
Kilvert, A., & Fox, C. (2023) · Practical Diabetes · doi:10.1002/pdi.2476 · Cited by 11
Song, S. H., & Gray, T. A. (2012) · QJM · doi:10.1093/qjmed/hcs113 · Cited by 8
Goldney, J., Barker, M. M., Sargeant, J. A., Daynes, E., Papamargaritis, D., Shabnam, S., Goff, L. M., Khunti, K., Henson, J., Davies, M. J., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112002 · Cited by 8
Self-citationJi, H., Ebinger, J. E., Kwan, A. C., Reue, K., Sullivan, J. C., Shyy, J., & Cheng, S. (2024) · Diabetes Care · doi:10.2337/dc23-2275 · Cited by 8
Li, Z., Luo, D., & Li, Z. (2025) · Endocrine Connections · doi:10.1530/ec-24-0576 · Cited by 6
Middleton, T. L., Constantino, M. I., McGill, M., D’Souza, M., Yue, D. K., Twigg, S. M., Wu, T., & Wong, J. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14621 · Cited by 2
980-P: Continuous Glucose Monitor Improves Glycemic Control in Youth-Onset Type 2 Diabetes
CHANG, N. T., SMITH, J. A., & CHAO, L. (2022) · Diabetes · doi:10.2337/db22-980-p
PATEL, T., ESTRADA, D. E., MEYERS, A., MACKEY, E., & CHUNG, S. T. (2024) · Diabetes · doi:10.2337/db24-1160-p
UKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Research works printed but not linked: 8
- IDF Diabetes Atlas 2021
- National diabetes statistics report
- Care processes and treatment targets
- 10.2337/figshare.13373708 · DOI · Paper page
- Arnett, 2019, 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, e563
- Type 1 diabetes in adults: diagnosis and management
- Type 2 diabetes in adults
- NHS Long Term Plan: Diabetes
Cited by
Kim, Y., Ha, J., & Moon, J. S. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2026.0034 · Cited by 8
Caba, M., Carvalho, M., Forbes, A., Forde, R., Gill, K., Khalifa, M., Parsons, J., Speight, J., Trief, P. M., & Hadjiconstantinou, M. (2026) · Diabetic Medicine · doi:10.1111/dme.70352 · Cited by 2
Wei, X., 梁宝兰, & Chen, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1778646 · Cited by 2
Li, J., Tang, G., Xie, Z., Yang, L., Zhou, Z., & Guo, K. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113101 · Cited by 1
Digital Management of Early-Onset Type 2 Diabetes: Empowerment, Challenges, and Future Outlook
Guo, L.-J., Low, K.-S., Tae, S.-K., & Lim, L.-L. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01633-6
Metadata
- Authors
- Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J.
- Affiliations
- University of Leicester (GB)
- University of Nottingham (GB)
- Corresponding author
- Davies, Melanie J.
- ORCID
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2025-09-01
- Volume
- 49
- Issue
- 5
- Pages
- 934-950
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- PMC
- PMC12436035
- OpenAlex
- W4414002032
- Semantic Scholar
- 83dd4a6029da4725478e4ba21e81cb1d81c081bb
- Cited by
- 11
- References
- 115
- Citations by year
- 2026: 10 · 2025: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Diabetes & Metabolism Journal (publishedVersion, cc-by-nc)
- Repository@Nottingham (University of Nottingham) (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute for Health and Care Research (NIHR201165)
- NIHR Leicester Biomedical Research Centre
- Applied Research Collaboration East Midlands
- Welcome Trust Leicestershire Healthcare Inequalities Improvement Doctoral Training Programme (223512/Z/21/Z)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- early-onset type 2 diabetes, young adults, diabetes management, bariatric surgery, tirzepatide, intensive lifestyle intervention, weight loss, beta-cell function, cardiometabolic risk, diabetes-related stigma, depression, psychological support, diabetes education, technology-based interventions, clinical inertia
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Humans, Life Style, Age of Onset, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-20, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-20 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.